Arrowhead Pharmaceuticals Liabilities 2025

Arrowhead Pharmaceuticals Aktienanalyse

What does Arrowhead Pharmaceuticals do?

Arrowhead Pharmaceuticals Inc is a biotechnology company that develops and commercializes RNA-based therapeutics. The company is headquartered in Pasadena, California and was founded in 2007. Arrowhead's history began when a group of scientists at the University of Texas came together to work on the development of RNA-based therapeutics. In 2007, Arrowhead was established and the company's patented TRiM™ (Targeted RNAi Molecules) technology was developed to specifically overcome barriers in RNAi-based therapeutics. The company is divided into several divisions, including Hepatitis B, cardiovascular, metabolic disorders, and oncology. Arrowhead has developed a range of RNAi-based investigational products, including ARC-520, which is being developed for the treatment of Hepatitis B and is currently in clinical trials. ARC-520 is designed to inhibit the formation and release of viral particles in liver cells, thereby halting the progression of the disease. Arrowhead has also developed products for the treatment of life-threatening diseases such as Alpha-1 Antitrypsin Deficiency (AAT) and hypertriglyceridemic pancreatitis (HTG). The treatments offered by Arrowhead aim to utilize RNA in disease treatment where other methods have failed. Arrowhead Pharmaceuticals Inc's business model is based on the discovery, development, and commercialization of RNAi-based therapeutics. The company collaborates with partners to accelerate the development and commercialization of its products. Arrowhead has a strategic partnership with Johnson & Johnson Pharmaceuticals Research & Development, LLC. Arrowhead Pharmaceuticals Inc is listed on the NASDAQ stock exchange under the ticker symbol ARWR. The company employs approximately 150 employees, including scientists, researchers, and specialists specialized in RNA biology. Recently, Arrowhead Pharmaceuticals Inc partnered with Takeda Pharmaceutical Co. Ltd. to develop RNAi-based therapeutics. This partnership aims to accelerate the development of RNAi-based therapeutics and optimize the company's potential in the field of RNA biology. In summary, Arrowhead Pharmaceuticals is a biotechnology company specializing in RNA biology. The company has developed a patented TRiM™ technology that specifically overcomes barriers in disease therapy with RNAi-based therapeutics. Arrowhead has developed several products for the treatment of life-threatening diseases and collaborates with partners to accelerate the development of its products and optimize commercialization. Arrowhead Pharmaceuticals Inc is an innovative player in the biotechnology field and strives to improve and revolutionize the common practice of RNAi-based therapeutics. Arrowhead Pharmaceuticals ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Liabilities Details

Assessing Arrowhead Pharmaceuticals's Liabilities

Arrowhead Pharmaceuticals's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating Arrowhead Pharmaceuticals's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing Arrowhead Pharmaceuticals's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

Arrowhead Pharmaceuticals's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in Arrowhead Pharmaceuticals’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about Arrowhead Pharmaceuticals stock

What is the level of liabilities of Arrowhead Pharmaceuticals this year?

Arrowhead Pharmaceuticals has a debt balance of 954.36 M USD this year.

What were the liabilities of Arrowhead Pharmaceuticals compared to the previous year?

The liabilities of Arrowhead Pharmaceuticals have increased by 93.11% increased compared to the previous year.

What are the consequences of high debt for investors of Arrowhead Pharmaceuticals?

High liabilities can pose a risk for investors of Arrowhead Pharmaceuticals, as they can weaken the company's financial position and impair its ability to meet its obligations.

What consequences do low liabilities have for investors in Arrowhead Pharmaceuticals?

Low liabilities mean that Arrowhead Pharmaceuticals has a strong financial position and is able to meet its obligations without overburdening its finances.

How does an increase in liabilities of Arrowhead Pharmaceuticals affect the company?

An increase in liabilities of Arrowhead Pharmaceuticals can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.

How does a reduction in the liabilities of Arrowhead Pharmaceuticals affect the company?

A decrease in the liabilities of Arrowhead Pharmaceuticals can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.

What are some factors that influence the liabilities of Arrowhead Pharmaceuticals?

Some factors that can influence the liabilities of Arrowhead Pharmaceuticals include investments, acquisitions, operating costs, and sales development.

Why is the level of liabilities of Arrowhead Pharmaceuticals so important for investors?

The liabilities of Arrowhead Pharmaceuticals are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.

What strategic measures can Arrowhead Pharmaceuticals take to modify the liabilities?

To change its liabilities, Arrowhead Pharmaceuticals can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.

How much dividend does Arrowhead Pharmaceuticals pay?

Over the past 12 months, Arrowhead Pharmaceuticals paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Arrowhead Pharmaceuticals is expected to pay a dividend of 0 USD.

What is the dividend yield of Arrowhead Pharmaceuticals?

The current dividend yield of Arrowhead Pharmaceuticals is .

When does Arrowhead Pharmaceuticals pay dividends?

Arrowhead Pharmaceuticals pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Arrowhead Pharmaceuticals?

Arrowhead Pharmaceuticals paid dividends every year for the past 0 years.

What is the dividend of Arrowhead Pharmaceuticals?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Arrowhead Pharmaceuticals located?

Arrowhead Pharmaceuticals is assigned to the 'Health' sector.

Wann musste ich die Aktien von Arrowhead Pharmaceuticals kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Arrowhead Pharmaceuticals from 3/4/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 3/4/2025.

When did Arrowhead Pharmaceuticals pay the last dividend?

The last dividend was paid out on 3/4/2025.

What was the dividend of Arrowhead Pharmaceuticals in the year 2024?

In the year 2024, Arrowhead Pharmaceuticals distributed 0 USD as dividends.

In which currency does Arrowhead Pharmaceuticals pay out the dividend?

The dividends of Arrowhead Pharmaceuticals are distributed in USD.